Evolving evidence on tumor and germline genetic classification of gliomas: implications for etiology and survival studies.
The Brain Tumor Epidemiology Consortium (BTEC) is an international consortium that has the mission of fostering the development of multi-center and inter-disciplinary collaborations aiming to improve understanding of the etiology, outcomes, and prevention of brain tumors. Mayo Clinic faculty, Robert Jenkins, MD, PhD and Brian Patrick O'Neill, MD, hosted the 16th annual BTEC meeting on June 2-4, 2015, in Rochester, MN, USA. The meeting included presentations that emphasized the impact of new tumor classifications, methodological practices of population studies, as well as intra- and inter-tumoral molecular complexities on patient outcomes. The 2016 meeting will be held in Barcelona, Spain in June.